checkAd
    Startseite > Aktien > Arbutus Biopharma > Nachrichten
    Arbutus Biopharma Aktie
    2,9000
     
    EUR
    -0,82 %
    -0,0240 EUR
    Letzter Kurs 16:34:06 Tradegate
    2,9000
     
    EUR
    1.730 STK
    Geldkurs 19:05:01
    2,9560
     
    EUR
    1.700 STK
    Briefkurs 19:05:01
    ISIN: CA03879J1003 · WKN: A14XMD · SYM: I9DN · Kanada

    Neueste Nachrichten

    Treatment with Arbutus’ Imdusiran and VTP-300 Achieves Statistical Significance in Lowering HBsAg Levels
    06.06.24 · globenewswire · Arbutus Biopharma
    Arbutus’ Imdusiran with Short Course Interferon Achieves Sustained Undetectable HBsAg, a Necessity for HBV Functional Cure
    05.06.24 · globenewswire · Arbutus Biopharma
    Arbutus to Participate in Jefferies Global Healthcare Conference
    29.05.24 · globenewswire · Arbutus Biopharma
    Arbutus to Present Imdusiran Data at EASL Congress 2024
    22.05.24 · globenewswire · Arbutus Biopharma
    Whitefort Capital Publishes Open Letter to Arbutus Biopharma Shareholders Outlining Paths to Maximize Value
    17.05.24 · Business Wire (engl.) · Arbutus Biopharma
    Arbutus to Participate in Two Upcoming Investor Conferences
    07.05.24 · globenewswire · Arbutus Biopharma
    Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
    02.05.24 · globenewswire · Arbutus Biopharma
    Arbutus Announces Retirement of Chief Scientific Officer, Michael J. Sofia, PhD, Effective December 31, 2024
    02.05.24 · globenewswire · Arbutus Biopharma
    Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update
    18.04.24 · globenewswire · Arbutus Biopharma
    Die größten Aufsteiger der Woche vom 03.04.-10.04.2024 in der wO Community
    10.04.24 · wO Chartvergleich · Bayer
    Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna
    04.04.24 · globenewswire · Arbutus Biopharma
    Arbutus to Participate in Two Upcoming Investor Conferences
    08.03.24 · globenewswire · Arbutus Biopharma